{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:38:00Z","timestamp":1769089080215,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":3031,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Few studies have reported the impact of high-dose loop diuretics at discharge on prognosis in Japanese patients with heart failure (HF). Our purpose was to assess the relationship between the dose of loop diuretics at discharge and cardiovascular mortality in patients with HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We enrolled decompensated HF patients who were admitted to our hospital between March 2010 and March 2015, and compared HF patients who received high-dose loop diuretics at discharge (HD group) with low-dose loop diuretics at discharge (LD group) with regard to risk of cardiovascular mortality, and all-cause mortality. High-dose loop diuretic was defined as \u226540 mg\/day of oral furosemide at discharge. A total of 215 patients were enrolled to the study. The median follow-up duration was 641 days. All-cause and cardiovascular mortality were significantly lower in the LD group than in the HD group (10.4% vs. 31.6%, P &amp;lt; 0.001; 2.2% vs. 24.6%, P &amp;lt; 0.001, respectively). High-dose loop diuretics were associated with cardiovascular mortality in multivariate Cox proportional hazards model (hazard ratio, 16.06, 95% confidence interval 3.457 to 116.8; P &amp;lt; 0.001). The largest area under the receiver operating characteristic curve (0.85) for cardiovascular death was obtained with a threshold of 40 mg furosemide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High-dose loop diuretic use at discharge was one of the predictors of cardiovascular mortality in patients with HF. An oral furosemide dose of 40 mg daily may be defined as \u2018high-dose\u2019 loop diuretics in Japanese patients with chronic HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12221","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T05:56:40Z","timestamp":1506923800000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Association Between High-Dose Loop Diuretic Use at Discharge and Cardiovascular Mortality in Patients with Heart Failure"],"prefix":"10.1093","volume":"5","author":[{"given":"Toshitaka","family":"Okabe","sequence":"first","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayuki","family":"Yakushiji","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Kido","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Oyama","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Igawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seitaro","family":"Ebara","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myong Hwa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisaki","family":"Amemiya","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoei","family":"Isomura","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Catheterization Laboratories, Showa University Northern Yokohama Hospital , 35-1, Chigasaki-Chuo, Tsuzuki, Yokohama, 224-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"key":"2026012115121069700_ehf212221-bib-0001","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2026012115121069700_ehf212221-bib-0002","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998\u20132008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"2026012115121069700_ehf212221-bib-0003","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2010.03.019","article-title":"Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data","volume":"159","author":"Sato","year":"2010","journal-title":"Am Heart J"},{"key":"2026012115121069700_ehf212221-bib-0004","doi-asserted-by":"crossref","first-page":"e001088","DOI":"10.1161\/JAHA.114.001088","article-title":"In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization","volume":"3. pii","author":"DeVore","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026012115121069700_ehf212221-bib-0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ahj.2010.07.020","article-title":"Generalizability and longitudinal outcomes of a national heart failure clinical registry: comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries","volume":"160","author":"Kociol","year":"2010","journal-title":"Am Heart J"},{"key":"2026012115121069700_ehf212221-bib-0006","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115121069700_ehf212221-bib-0007","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"2026012115121069700_ehf212221-bib-0008","article-title":"Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function","author":"Breidthardt","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115121069700_ehf212221-bib-0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Prospective Randomized Amlodipine Survival Evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"2026012115121069700_ehf212221-bib-0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardfail.2008.01.015","article-title":"The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients","volume":"14","author":"Mielniczuk","year":"2008","journal-title":"J Card Fail"},{"key":"2026012115121069700_ehf212221-bib-0011","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.amjcard.2011.03.062","article-title":"Validation of mortality risk stratification models for cardiovascular disease","volume":"108","author":"Nakayama","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026012115121069700_ehf212221-bib-0012","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026012115121069700_ehf212221-bib-0013","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"2026012115121069700_ehf212221-bib-0014","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","article-title":"Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)","volume":"73","author":"Tsuchihashi-Makaya","year":"2009","journal-title":"Circ J"},{"key":"2026012115121069700_ehf212221-bib-0015","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"28","author":"Arrigo","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115121069700_ehf212221-bib-0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cardfail.2016.07.001","article-title":"2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America","volume":"22","author":"Yancy","year":"2016","journal-title":"J Card Fail"},{"key":"2026012115121069700_ehf212221-bib-0017","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026012115121069700_ehf212221-bib-0018","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026012115121069700_ehf212221-bib-0019","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","article-title":"Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure","volume":"43","author":"Logeart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026012115121069700_ehf212221-bib-0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"key":"2026012115121069700_ehf212221-bib-0021","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J Card Fail"},{"key":"2026012115121069700_ehf212221-bib-0022","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115121069700_ehf212221-bib-0023","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1388-9842(02)00205-2","article-title":"Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function","volume":"5","author":"van Kraaij","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"2026012115121069700_ehf212221-bib-0024","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"key":"2026012115121069700_ehf212221-bib-0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026012115121069700_ehf212221-bib-0026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","article-title":"Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry","volume":"113","author":"Peacock","year":"2009","journal-title":"Cardiology"},{"key":"2026012115121069700_ehf212221-bib-0027","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1755-5922.12142","article-title":"The efficacy of tolvaptan in congestive heart failure patients with and without hypoalbuminemia: a pilot study","volume":"33","author":"Okabe","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"2026012115121069700_ehf212221-bib-0028","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"2026012115121069700_ehf212221-bib-0029","first-page":"35321","article-title":"Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure","volume":"S0735-1097","author":"Felker","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012115121069700_ehf212221-bib-0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2011.01.052","article-title":"Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure","volume":"58","author":"Testani","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012115121069700_ehf212221-bib-0031","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCULATIONAHA.106.679779","article-title":"Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"116","author":"Kenchaiah","year":"2007","journal-title":"Circulation"},{"key":"2026012115121069700_ehf212221-bib-0032","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","article-title":"Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion","volume":"297","author":"Intersalt Cooperative Research Group","year":"1988","journal-title":"BMJ"},{"key":"2026012115121069700_ehf212221-bib-0033","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1253\/circj.CJ-16-0216","article-title":"Prognostic impact of loop diuretics in patients with chronic heart failure\u2014effects of addition of renin\u2013angiotensin\u2013aldosterone system inhibitors and \u03b2-blockers","volume":"80","author":"Miura","year":"2016","journal-title":"Circ J"},{"key":"2026012115121069700_ehf212221-bib-0034","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ejhf.443","article-title":"Optimizing clinical use of biomarkers in high-risk acute heart failure patients","volume":"18","author":"Demissei","year":"2016","journal-title":"Eur J Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12221","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/1\/87\/66137605\/eschf_5_1_87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/1\/87\/66137605\/eschf_5_1_87.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:16:26Z","timestamp":1769026586000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/5\/1\/87\/8403962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,2]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12221","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,10,2]]},"assertion":[{"value":"2017-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}